Citius Pharmaceuticals, Inc. Increase (Decrease) in Accrued Interest Receivable, Net
Citius Pharmaceuticals, Inc. (CTXR) reported Increase (Decrease) in Accrued Interest Receivable, Net of -$394.73 thousand for the 12-month period ending 2023-09-30, per its 10-K filed 2023-12-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedInterestReceivableNet · last filed 2023-12-29
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued interest receivable, net for the quarter ending 2023-09-30 was -$551.54K.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued interest receivable, net for the quarter ending 2023-06-30 was -$579.67K.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued interest receivable, net for the quarter ending 2023-03-31 was $1.08M, a 24.94% decline year-over-year.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued interest receivable, net for the quarter ending 2022-12-31 was -$344.76K.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued interest receivable, net for fiscal 2023 was -$394.73K, a 374.60% decline from fiscal 2022.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued interest receivable, net for fiscal 2022 was $143.75K, a 63.36% increase from fiscal 2021.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued interest receivable, net for fiscal 2021 was $88.00K.
- Citius Pharmaceuticals, Inc. increase (decrease) in accrued interest receivable, net for fiscal 2020 was -$15.67K.
| Period end | Increase (Decrease) in Accrued Interest Receivable, Net 3 month | Increase (Decrease) in Accrued Interest Receivable, Net 6 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month | Increase (Decrease) in Accrued Interest Receivable, Net 9 month as first filed | Increase (Decrease) in Accrued Interest Receivable, Net 12 month | Increase (Decrease) in Accrued Interest Receivable, Net 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-09-30 | -$551.54K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-29 | -$1.13M derived: sum of 2 quarters · filed 2023-12-29 | -$49.97K derived: sum of 3 quarters · filed 2023-12-29 | -$394.73K 10-K · filed 2023-12-29 | ||
| 2023-06-30 | -$579.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $501.57K derived: sum of 2 quarters · filed 2023-08-14 | $156.81K 10-Q · filed 2023-08-14 | -$327.94K derived: sum of 4 quarters · filed 2023-12-29 | ||
| 2023-03-31 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $736.47K 10-Q · filed 2023-05-12 | $251.72K derived: sum of 3 quarters · filed 2023-12-29 | -$232.53K derived: sum of 4 quarters · filed 2023-12-29 | ||
| 2022-12-31 | -$344.76K 10-Q · filed 2023-02-10 | -$829.51K derived: sum of 2 quarters · filed 2023-12-29 | -$1.31M derived: sum of 3 quarters · filed 2023-12-29 | $126.68K derived: sum of 4 quarters · filed 2023-12-29 | ||
| 2022-09-30 | -$484.75K derived: 10-K 12 month − 10-Q 9 month · filed 2023-12-29 | -$969.00K derived: sum of 2 quarters · filed 2023-12-29 | $471.44K derived: sum of 3 quarters · filed 2023-12-29 | $143.75K 10-K · filed 2023-12-29 | ||
| 2022-06-30 | -$484.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-14 | $956.19K derived: sum of 2 quarters · filed 2023-08-14 | $628.50K 10-Q · filed 2023-08-14 | $628.50K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-12 | $1.11M 10-Q · filed 2023-05-12 | $1.11M derived: sum of 3 quarters · filed 2023-05-12 | $1.21M derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | -$327.69K 10-Q · filed 2023-02-10 | -$327.69K derived: sum of 2 quarters · filed 2023-02-10 | -$231.79K derived: sum of 3 quarters · filed 2023-02-10 | -$235.73K derived: sum of 4 quarters · filed 2023-02-10 | ||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $95.90K derived: sum of 2 quarters · filed 2022-12-22 | $91.96K derived: sum of 3 quarters · filed 2022-12-22 | $88.00K 10-K · filed 2022-12-22 | ||
| 2021-06-30 | $95.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $91.96K derived: sum of 2 quarters · filed 2022-08-11 | $88.00K 10-Q · filed 2022-08-11 | $84.54K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$3.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-12 | -$7.91K 10-Q · filed 2022-05-12 | -$11.36K derived: sum of 3 quarters · filed 2022-05-12 | -$15.61K derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$3.97K 10-Q · filed 2022-02-10 | -$7.42K derived: sum of 2 quarters · filed 2022-02-10 | -$11.67K derived: sum of 3 quarters · filed 2022-02-10 | -$15.65K derived: sum of 4 quarters · filed 2022-02-10 | ||
| 2020-09-30 | -$3.46K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-15 | -$7.70K derived: sum of 2 quarters · filed 2021-12-15 | -$11.68K derived: sum of 3 quarters · filed 2021-12-15 | -$15.67K 10-K · filed 2021-12-15 | ||
| 2020-06-30 | -$4.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-12 | -$8.22K derived: sum of 2 quarters · filed 2021-08-12 | -$12.22K 10-Q · filed 2021-08-12 | -$16.41K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | -$3.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-05-13 | -$7.97K 10-Q · filed 2021-05-13 | -$12.17K derived: sum of 3 quarters · filed 2021-05-13 | -$16.31K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | -$3.99K 10-Q · filed 2021-02-11 | -$8.19K derived: sum of 2 quarters · filed 2021-02-11 | -$12.33K derived: sum of 3 quarters · filed 2021-02-11 | -$16.43K derived: sum of 4 quarters · filed 2021-02-11 | ||
| 2019-09-30 | -$4.20K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-16 | -$8.34K derived: sum of 2 quarters · filed 2020-12-16 | -$12.44K derived: sum of 3 quarters · filed 2020-12-16 | -$16.44K 10-K · filed 2020-12-16 | ||
| 2019-06-30 | -$4.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-14 | -$8.24K derived: sum of 2 quarters · filed 2020-08-14 | -$12.25K 10-Q · filed 2020-08-14 | -$16.09K derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | -$4.11K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-14 | -$8.11K 10-Q · filed 2020-05-14 | -$11.96K derived: sum of 3 quarters · filed 2020-05-14 | -$15.86K derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2018-12-31 | -$4.00K 10-Q · filed 2020-02-13 | -$7.85K derived: sum of 2 quarters · filed 2020-02-13 | -$11.75K derived: sum of 3 quarters · filed 2020-02-13 | -$16.46K derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-09-30 | -$3.85K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | -$7.75K derived: sum of 2 quarters · filed 2019-12-16 | -$12.45K derived: sum of 3 quarters · filed 2019-12-16 | -$15.64K 10-K · filed 2019-12-16 | ||
| 2018-06-30 | -$3.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | -$8.61K derived: sum of 2 quarters · filed 2019-08-14 | -$11.80K 10-Q · filed 2019-08-14 | -$32.90K derived: sum of 4 quarters · filed 2019-12-16 | ||
| 2018-03-31 | -$4.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | -$7.90K 10-Q · filed 2019-05-15 | -$29.00K derived: sum of 3 quarters · filed 2019-12-16 | -$62.40K derived: sum of 4 quarters · filed 2019-12-16 | ||
| 2017-12-31 | -$3.19K 10-Q · filed 2019-02-14 | -$24.29K derived: sum of 2 quarters · filed 2019-12-16 | -$57.69K derived: sum of 3 quarters · filed 2019-12-16 | -$77.54K derived: sum of 4 quarters · filed 2019-12-16 | ||
| 2017-09-30 | -$21.10K derived: 10-K 12 month − 10-Q 9 month · filed 2019-12-16 | -$54.50K derived: sum of 2 quarters · filed 2019-12-16 | -$74.35K derived: sum of 3 quarters · filed 2019-12-16 | -$87.58K 10-K · filed 2019-12-16 | ||
| 2017-06-30 | -$33.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-14 | -$53.25K derived: sum of 2 quarters · filed 2018-08-14 | -$66.48K 10-Q · filed 2018-08-14 | -$71.03K derived: sum of 4 quarters · filed 2018-12-11 | ||
| 2017-03-31 | -$19.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-11 | -$33.08K 10-Q · filed 2018-05-11 | -$37.63K derived: sum of 3 quarters · filed 2018-12-11 | |||
| 2016-12-31 | -$13.23K 10-Q · filed 2018-02-14 | -$17.78K derived: sum of 2 quarters · filed 2018-12-11 | ||||
| 2016-09-30 | -$4.55K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-11 | -$7.01K 10-K · filed 2018-12-11 | $7.01K 10-K · filed 2016-12-23 | |||
| 2016-06-30 | -$2.46K 10-Q · filed 2017-08-14 | $2.46K 10-Q · filed 2016-08-15 | ||||
| 2015-09-30 | -$15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-12-13 | -$15.00K derived: sum of 2 quarters · filed 2017-12-13 | -$15.00K derived: sum of 3 quarters · filed 2017-12-13 | -$7.50K 10-K · filed 2017-12-13 | $7.50K 10-K · filed 2015-12-14 | |
| 2015-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-15 | $0.00 derived: sum of 2 quarters · filed 2016-08-15 | $7.50K 10-Q · filed 2016-08-15 | $1.82K derived: sum of 4 quarters · filed 2016-12-23 | ||
| 2015-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-20 | $7.50K 10-Q · filed 2016-05-20 | $1.82K derived: sum of 3 quarters · filed 2016-12-23 | $31.90K derived: sum of 4 quarters · filed 2016-12-23 | ||
| 2014-12-31 | $7.50K 10-Q · filed 2016-02-12 | $1.82K derived: sum of 2 quarters · filed 2016-12-23 | $31.90K derived: sum of 3 quarters · filed 2016-12-23 | $61.85K derived: sum of 4 quarters · filed 2016-12-23 | ||
| 2014-09-30 | -$5.68K derived: 10-K 12 month − 10-Q 9 month · filed 2016-12-23 | $24.40K derived: sum of 2 quarters · filed 2016-12-23 | $79.07K 10-K · filed 2015-12-14 | $79.07K 10-K · filed 2016-12-23 | ||
| 2014-06-30 | $30.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-13 | $60.02K derived: sum of 2 quarters · filed 2015-08-13 | $84.75K 10-Q · filed 2015-08-13 | |||
| 2014-03-31 | $29.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-13 | $54.67K 10-Q · filed 2015-05-13 | ||||
| 2013-12-31 | $24.72K 10-Q · filed 2015-02-17 | $77.47K 10-K · filed 2015-12-14 | ||||
| 2012-12-31 | $33.31K 10-KT · filed 2014-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |